ACADIA Pharmaceuticals, Inc. is a pharmaceutical company based in the United States of America. It focuses on developing and commercializing biopharmaceutical products for central nervous system disorders. The company aims to discover small molecules drugs to treat conditions like Parkinson's, Alzheimer's, and schizophrenia. ACADIA also looks to in-license or acquire complementary products and candidates. With a Risk Rating Score of 24.1, the company is considered to have a medium risk assessment. ACADIA Pharmaceuticals holds patent applications for proprietary technology related to screening methods, drug targets, and compounds. Invest in pharmaceutical innovation with ACADIA Pharmaceuticals, a leader in ESG focused biotechnology.